60 day FRN

25295

Federal Register / Vol. 90, No. 114 / Monday, June 16, 2025 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents

State, Territory, and New Mexico
County Officials.
Total ...........................................

Annual Vital Statistics Occurrence
Report.
...........................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–10858 Filed 6–13–25; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–0600; Docket No. CDC–2025–
0015]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled, CDC Model
Performance Evaluation Program
(MPEP) for Mycobacterium tuberculosis
Drug Susceptibility Testing. CDC is
requesting a three-year approval for
extension of the currently approved
project used to monitor and evaluate
performances and practices among
national laboratories’ M. tuberculosis
susceptibility testing.
DATES: CDC must receive written
comments on or before August 15, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2025–
0015 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for

ddrumheller on DSK120RN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

18:38 Jun 13, 2025

Jkt 265001

Number of
responses per
respondent

Number of
respondents

Form name

Frm 00095

Fmt 4703

Total burden
(in hours)

91

1

30/60

46

........................

........................

........................

46

Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

PO 00000

Average
burden per
response
(in hours)

Sfmt 4703

3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility Testing
(OMB Control No. 0920–0600, Exp. 9/
30/2025)—Extension—National Center
for HIV, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC is requesting an Extension of
a currently approved information
collection request (ICR) titled CDC
Model Performance Evaluation Program
(MPEP) for Mycobacterium tuberculosis
(TB) Drug Susceptibility Testing for a
period of three years. The Extension
submitted for this ICR will not require
changes in the scope of the project.
As part of the Extension, CDC is
requesting a non-substantive change to
the title of the data collection to CDC
Model Performance Evaluation (MPEP)
for Mycobacterium tuberculosis Drug
Susceptibility Testing to reflect that
nontuberculous mycobacteria are no
longer included in the program.
While the overall number of cases of
TB in the U.S. has remained fairly
stable, rates still remain high among
foreign-born persons, persons in
correctional facilities, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
for Mycobacterium tuberculosis drug
susceptibility testing is used to monitor
and evaluate performance and practices
among U.S. laboratories performing M.
tuberculosis susceptibility testing.
Participation in this program is one way

E:\FR\FM\16JNN1.SGM

16JNN1

25296

Federal Register / Vol. 90, No. 114 / Monday, June 16, 2025 / Notices

laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
Providing an evaluation program to
assess the ability of laboratories to test
for drug resistant M. tuberculosis
strains, gives laboratories a selfassessment tool to aid in optimizing
their skills in susceptibility testing. The
information obtained from the
laboratories on susceptibility practices
and procedures is used to inform
continuous program improvement
related to good performance, training
needs, and the development of practice
standards. Participants in this program
include domestic clinical and public
health laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program

will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) isolates.
The PE isolates are sent to participating
laboratories twice a year. Participants
also report laboratory demographic data
such as laboratory type and the number
of drug susceptibility tests performed
annually.
Over the past three years, six final
MPEP reports have been distributed and
published with an average of 58
participants per MPEP isolate shipment.
All state public health laboratories that
perform Mycobacterium tuberculosis
drug susceptibility testing participated
in MPEP, along with approximately
seven hospital, seven independent/

reference, and two federal laboratories;
these participating laboratories
represent geographical and laboratory
type variation. Drug susceptibility
testing results met consensus for 73% or
22 isolates of the six panels with five
isolates each (30) for first-line drugs,
highlighting challenges that laboratories
experience with current testing
practices and methods. MPEP continues
to select isolates with both common and
challenging resistance patterns for
educational value.
CDC is requesting approval for 113
burden hours, a reduction of 16 burden
hours due to the reduction in the
number of respondents. There is no cost
to respondents to participate other than
their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(hours)

Total
burden
(hours)

Form name

Domestic Laboratory ............................

Participant Biosafety Compliance Agreement.
MPEP Mycobacterium tuberculosis Results
Worksheet.
Online Survey Instrument ...........................
MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration (MIC) Results Form.

70

1

5/60

6

70

2

30/60

70

70
4

2
2

15/60
15/60

35
2

.....................................................................

........................

........................

....................

113

Total ...............................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–10860 Filed 6–13–25; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–0010; Docket No. CDC–2025–
0009]

CDC must receive written
comments on or before August 15, 2025.

Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the

VerDate Sep<11>2014

18:38 Jun 13, 2025

Jkt 265001

You may submit comments,
identified by Docket No. CDC–2025–
0009 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.

ADDRESSES:

AGENCY:

SUMMARY:

general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Exposures,
Health Effects, and Controls of
Chemicals from Thermal Spray Coating:
Part 2. The purpose of the proposed data
collection is to assess exposures and
respiratory health in workers using
three thermal commonly used spray
coating technologies and to investigate
the association between exposures and
respiratory health.
DATES:

Proposed Data Collection Submitted
for Public Comment and
Recommendations
ddrumheller on DSK120RN23PROD with NOTICES1

Number of
respondents

Type of respondent

PO 00000

Frm 00096

Fmt 4703

Sfmt 4703

Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of

E:\FR\FM\16JNN1.SGM

16JNN1